Not All AI Is Equal – and Clinical Governance Depends on Knowing the Difference

Key Takeaways

• LLMs generate plausible text but lack reproducibility and auditability.
• Clinical tasks needing exhaustive retrieval require deterministic algorithmic AI.
• Governance often treats AI as monolithic, ignoring architectural differences.
• Audit trails for AI outputs are essential for safe clinical decisions.
• Procurement should demand traceability and human review for generative AI.

Pulse Analysis

The surge of artificial intelligence in health systems reflects mounting pressure on clinicians and administrators. From automated note‑taking to triage routing, AI promises efficiency gains that could offset chronic workforce shortages. Yet the market’s enthusiasm has been driven largely by the public success of large language models such as ChatGPT, leading many purchasers to label any machine‑learning tool as "AI" without scrutinising its underlying mechanics. This conflation masks the fact that the AI landscape includes rule‑based engines, decision trees, and statistical classifiers that operate on deterministic logic, each with distinct risk profiles.

Understanding the technical divide is crucial for patient safety. Large language models excel at generating fluent text but produce outputs based on probability, not guaranteed correctness; the same prompt can yield divergent answers, and fabricated details may slip in unnoticed. In contrast, deterministic algorithms retrieve or compute information from defined data sources, delivering repeatable results essential for drug‑interaction checks, radiology decision support, and regulatory audits. Deploying a generative model in these high‑stakes contexts can introduce errors that are difficult to trace, undermining clinical confidence and exposing organisations to liability.

Effective governance must evolve beyond bias and performance metrics to demand auditability and traceability. Procurement teams should require vendors to expose input‑output logs, version control, and reproducible pipelines, especially for systems that influence clinical pathways. Human oversight remains mandatory for generative outputs, limiting their use to draft communications or administrative summaries. By aligning AI selection with task‑specific requirements and embedding robust logging standards, health providers can harness innovation while preserving the evidentiary rigor that underpins modern medicine.